AEM-28: Phase Ib/IIa ongoing

LipimetiX Development LLC began the multiple ascending-dose portion of a double-blind, placebo-controlled, Australian Phase Ib/IIa trial of

Read the full 174 word article

How to gain access

Continue reading with a
two-week free trial.